Anti-inflammatory Therapeutics Industry Research Report 2025

Summary

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

According to APO Research, The global Anti-inflammatory Therapeutics market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Anti-inflammatory Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Anti-inflammatory Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Anti-inflammatory Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Anti-inflammatory Therapeutics include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck and Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Therapeutics.
The Anti-inflammatory Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-inflammatory Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Anti-inflammatory Therapeutics Segment by Company

AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
Anti-inflammatory Therapeutics Segment by Type

Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
Anti-inflammatory Therapeutics Segment by Application

Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Anti-inflammatory Therapeutics Segment by Application

Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Anti-inflammatory Therapeutics Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Anti-inflammatory Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Anti-inflammatory Therapeutics by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Anti-inflammatory Biologics
2.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
2.2.4 Corticosteroids
2.2.5 Others
2.3 Anti-inflammatory Therapeutics by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Arthritis
2.3.3 Respiratory Diseases
2.3.4 Dermatology
2.3.5 Gastroenterology
2.3.6 Others
2.4 Assumptions and Limitations
3 Anti-inflammatory Therapeutics Breakdown Data by Type
3.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2020-2025)
3.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2026-2031)
4 Anti-inflammatory Therapeutics Breakdown Data by Application
4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Application (2020-2025)
4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Anti-inflammatory Therapeutics Market Perspective (2020-2031)
5.2 Global Anti-inflammatory Therapeutics Growth Trends by Region
5.2.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Anti-inflammatory Therapeutics Historic Market Size by Region (2020-2025)
5.2.3 Anti-inflammatory Therapeutics Forecasted Market Size by Region (2026-2031)
5.3 Anti-inflammatory Therapeutics Market Dynamics
5.3.1 Anti-inflammatory Therapeutics Industry Trends
5.3.2 Anti-inflammatory Therapeutics Market Drivers
5.3.3 Anti-inflammatory Therapeutics Market Challenges
5.3.4 Anti-inflammatory Therapeutics Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Anti-inflammatory Therapeutics Players by Revenue
6.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2020-2025)
6.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2020-2025)
6.2 Global Anti-inflammatory Therapeutics Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Anti-inflammatory Therapeutics Head Office and Area Served
6.4 Global Anti-inflammatory Therapeutics Players, Product Type & Application
6.5 Global Anti-inflammatory Therapeutics Manufacturers Established Date
6.6 Global Anti-inflammatory Therapeutics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Anti-inflammatory Therapeutics Market Size (2020-2031)
7.2 North America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
7.4 North America Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Anti-inflammatory Therapeutics Market Size (2020-2031)
8.2 Europe Anti-inflammatory Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
8.4 Europe Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size (2020-2031)
9.2 Asia-Pacific Anti-inflammatory Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
9.4 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Anti-inflammatory Therapeutics Market Size (2020-2031)
10.2 South America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
10.4 South America Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size (2020-2031)
11.2 Middle East & Africa Anti-inflammatory Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
11.4 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 AbbVie
12.1.1 AbbVie Company Information
12.1.2 AbbVie Business Overview
12.1.3 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
12.1.4 AbbVie Anti-inflammatory Therapeutics Product Portfolio
12.1.5 AbbVie Recent Developments
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Information
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
12.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Product Portfolio
12.2.5 Johnson & Johnson Recent Developments
12.3 Amgen Inc
12.3.1 Amgen Inc Company Information
12.3.2 Amgen Inc Business Overview
12.3.3 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
12.3.4 Amgen Inc Anti-inflammatory Therapeutics Product Portfolio
12.3.5 Amgen Inc Recent Developments
12.4 AstraZeneca PLC
12.4.1 AstraZeneca PLC Company Information
12.4.2 AstraZeneca PLC Business Overview
12.4.3 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
12.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Product Portfolio
12.4.5 AstraZeneca PLC Recent Developments
12.5 Pfizer, Inc
12.5.1 Pfizer, Inc Company Information
12.5.2 Pfizer, Inc Business Overview
12.5.3 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
12.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Product Portfolio
12.5.5 Pfizer, Inc Recent Developments
12.6 Novartis
12.6.1 Novartis Company Information
12.6.2 Novartis Business Overview
12.6.3 Novartis Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
12.6.4 Novartis Anti-inflammatory Therapeutics Product Portfolio
12.6.5 Novartis Recent Developments
12.7 Roche
12.7.1 Roche Company Information
12.7.2 Roche Business Overview
12.7.3 Roche Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
12.7.4 Roche Anti-inflammatory Therapeutics Product Portfolio
12.7.5 Roche Recent Developments
12.8 Merck
12.8.1 Merck Company Information
12.8.2 Merck Business Overview
12.8.3 Merck Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
12.8.4 Merck Anti-inflammatory Therapeutics Product Portfolio
12.8.5 Merck Recent Developments
12.9 Sanofi
12.9.1 Sanofi Company Information
12.9.2 Sanofi Business Overview
12.9.3 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
12.9.4 Sanofi Anti-inflammatory Therapeutics Product Portfolio
12.9.5 Sanofi Recent Developments
12.10 GlaxoSmithKline
12.10.1 GlaxoSmithKline Company Information
12.10.2 GlaxoSmithKline Business Overview
12.10.3 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
12.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Product Portfolio
12.10.5 GlaxoSmithKline Recent Developments
12.11 Sun Pharmaceutical Industries Ltd
12.11.1 Sun Pharmaceutical Industries Ltd Company Information
12.11.2 Sun Pharmaceutical Industries Ltd Business Overview
12.11.3 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
12.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Portfolio
12.11.5 Sun Pharmaceutical Industries Ltd Recent Developments
12.12 TEVA
12.12.1 TEVA Company Information
12.12.2 TEVA Business Overview
12.12.3 TEVA Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
12.12.4 TEVA Anti-inflammatory Therapeutics Product Portfolio
12.12.5 TEVA Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings